New antiepileptic drugs, cost-efficacy analysis
Objective: to optimize pharmacotherapy in patients with epilepsy and to evaluate the clinical and cost-effectiveness of its therapy with the new antiepileptic drugs (AED): levetiracetam, lamotrigine, topiramate, and oxcarbazepine.Patients and methods. The study enrolled 134 patients (women, 69.03%;...
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russian |
| Publicado: |
IMA-PRESS LLC
2014-01-01
|
| Series: | Неврология, нейропсихиатрия, психосоматика |
| Subjects: | |
| Acceso en liña: | https://nnp.ima-press.net/nnp/article/view/226 |